These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
272 related items for PubMed ID: 37373116
1. Lysophosphatidic Acid Induces Podocyte Pyroptosis in Diabetic Nephropathy by an Increase of Egr1 Expression via Downregulation of EzH2. Kim D, Ban KY, Lee GH, Jun HS. Int J Mol Sci; 2023 Jun 09; 24(12):. PubMed ID: 37373116 [Abstract] [Full Text] [Related]
2. STING deletion alleviates podocyte injury through suppressing inflammation by targeting NLRP3 in diabetic kidney disease. Yang X, Chen Z, Luo Z, Yang D, Hao Y, Hu J, Feng J, Zhu Z, Luo Q, Zhang Z, Liang W, Ding G. Cell Signal; 2023 Sep 09; 109():110777. PubMed ID: 37329999 [Abstract] [Full Text] [Related]
3. Astragaloside IV Attenuates High-Glucose-Induced Impairment in Diabetic Nephropathy by Increasing Klotho Expression via the NF-κB/NLRP3 Axis. He J, Cui J, Shi Y, Wang T, Xin J, Li Y, Shan X, Zhu Z, Gao Y. J Diabetes Res; 2023 Sep 09; 2023():7423661. PubMed ID: 37261217 [Abstract] [Full Text] [Related]
4. Lysophosphatidic acid receptor 1 inhibitor, AM095, attenuates diabetic nephropathy in mice by downregulation of TLR4/NF-κB signaling and NADPH oxidase. Lee JH, Sarker MK, Choi H, Shin D, Kim D, Jun HS. Biochim Biophys Acta Mol Basis Dis; 2019 Jun 01; 1865(6):1332-1340. PubMed ID: 30763641 [Abstract] [Full Text] [Related]
5. Epigenetic regulation of TXNIP-mediated oxidative stress and NLRP3 inflammasome activation contributes to SAHH inhibition-aggravated diabetic nephropathy. Dai X, Liao R, Liu C, Liu S, Huang H, Liu J, Jin T, Guo H, Zheng Z, Xia M, Ling W, Xiao Y. Redox Biol; 2021 Sep 01; 45():102033. PubMed ID: 34119876 [Abstract] [Full Text] [Related]
6. NLRP3 inflammasome negatively regulates podocyte autophagy in diabetic nephropathy. Hou Y, Lin S, Qiu J, Sun W, Dong M, Xiang Y, Wang L, Du P. Biochem Biophys Res Commun; 2020 Jan 15; 521(3):791-798. PubMed ID: 31703838 [Abstract] [Full Text] [Related]
7. WT1 ameliorates podocyte injury via repression of EZH2/β-catenin pathway in diabetic nephropathy. Wan J, Hou X, Zhou Z, Geng J, Tian J, Bai X, Nie J. Free Radic Biol Med; 2017 Jul 15; 108():280-299. PubMed ID: 28315733 [Abstract] [Full Text] [Related]
8. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy. Wu M, Yang Z, Zhang C, Shi Y, Han W, Song S, Mu L, Du C, Shi Y. Metabolism; 2021 May 15; 118():154748. PubMed ID: 33675822 [Abstract] [Full Text] [Related]
9. Breviscapine alleviates podocyte injury by inhibiting NF-κB/NLRP3-mediated pyroptosis in diabetic nephropathy. Sun L, Ding M, Chen F, Zhu D, Xie X. PeerJ; 2023 May 15; 11():e14826. PubMed ID: 36815984 [Abstract] [Full Text] [Related]
10. ManNAc protects against podocyte pyroptosis via inhibiting mitochondrial damage and ROS/NLRP3 signaling pathway in diabetic kidney injury model. Gao Y, Ma Y, Xie D, Jiang H. Int Immunopharmacol; 2022 Jun 15; 107():108711. PubMed ID: 35338958 [Abstract] [Full Text] [Related]
11. Spop ameliorates diabetic nephropathy through restraining NLRP3 inflammasome. Wang B, Dai Z, Gao Q, Liu Y, Gu G, Zheng H. Biochem Biophys Res Commun; 2022 Feb 26; 594():131-138. PubMed ID: 35081502 [Abstract] [Full Text] [Related]
12. Artificially Cultivated Ophiocordyceps sinensis Alleviates Diabetic Nephropathy and Its Podocyte Injury via Inhibiting P2X7R Expression and NLRP3 Inflammasome Activation. Wang C, Hou XX, Rui HL, Li LJ, Zhao J, Yang M, Sun LJ, Dong HR, Cheng H, Chen YP. J Diabetes Res; 2018 Feb 26; 2018():1390418. PubMed ID: 30534570 [Abstract] [Full Text] [Related]
13. Triptolide protects against podocyte injury in diabetic nephropathy by activating the Nrf2/HO-1 pathway and inhibiting the NLRP3 inflammasome pathway. Lv C, Cheng T, Zhang B, Sun K, Lu K. Ren Fail; 2023 Dec 26; 45(1):2165103. PubMed ID: 36938748 [Abstract] [Full Text] [Related]
14. FOXM1-activated SIRT4 inhibits NF-κB signaling and NLRP3 inflammasome to alleviate kidney injury and podocyte pyroptosis in diabetic nephropathy. Xu X, Zhang L, Hua F, Zhang C, Zhang C, Mi X, Qin N, Wang J, Zhu A, Qin Z, Zhou F. Exp Cell Res; 2021 Nov 15; 408(2):112863. PubMed ID: 34626587 [Abstract] [Full Text] [Related]
15. The Histone Methyltransferase Enzyme Enhancer of Zeste Homolog 2 Protects against Podocyte Oxidative Stress and Renal Injury in Diabetes. Siddiqi FS, Majumder S, Thai K, Abdalla M, Hu P, Advani SL, White KE, Bowskill BB, Guarna G, Dos Santos CC, Connelly KA, Advani A. J Am Soc Nephrol; 2016 Jul 15; 27(7):2021-34. PubMed ID: 26534922 [Abstract] [Full Text] [Related]
16. Caspase-11/4 and gasdermin D-mediated pyroptosis contributes to podocyte injury in mouse diabetic nephropathy. Cheng Q, Pan J, Zhou ZL, Yin F, Xie HY, Chen PP, Li JY, Zheng PQ, Zhou L, Zhang W, Liu J, Lu LM. Acta Pharmacol Sin; 2021 Jun 15; 42(6):954-963. PubMed ID: 32968210 [Abstract] [Full Text] [Related]
17. TRIM29 promotes podocyte pyroptosis in diabetic nephropathy through the NF-kB/NLRP3 inflammasome pathway. Xu X, Qin Z, Zhang C, Mi X, Zhang C, Zhou F, Wang J, Zhang L, Hua F. Cell Biol Int; 2023 Jun 15; 47(6):1126-1135. PubMed ID: 36841942 [Abstract] [Full Text] [Related]
18. Astragaloside IV ameliorates diabetic nephropathy in db/db mice by inhibiting NLRP3 inflammasome‑mediated inflammation. Feng H, Zhu X, Tang Y, Fu S, Kong B, Liu X. Int J Mol Med; 2021 Aug 15; 48(2):. PubMed ID: 34278447 [Abstract] [Full Text] [Related]
19. LncRNA 1500026H17Rik knockdown ameliorates high glucose-induced mouse podocyte injuries through the miR-205-5p/EGR1 pathway. Xia J, Sun W, Dun J. Int Urol Nephrol; 2023 Apr 15; 55(4):1045-1057. PubMed ID: 36306049 [Abstract] [Full Text] [Related]
20. [Hepatitis B virus X protein promotes podocyte pyroptosis in hepatitis B virus-associated glomerulonephritis by down-regulating microRNA -223 targeting NLRP3 inflammasome]. Yu YN, Chen YQ, Li BS, Yang XQ, Feng MX, Jiang W. Zhonghua Gan Zang Bing Za Zhi; 2023 Jan 15; 39(1):20-31. PubMed ID: 36776011 [Abstract] [Full Text] [Related] Page: [Next] [New Search]